'Hiv drug resistance' presentation slideshows

Overview of HIV Disease

1.08k views • 91 slides

2003 Cumulative Number of AIDS deaths: North America 20,000 500,000

HIV/AIDS in 2004*. 2003 Cumulative Number of AIDS deaths: North America 20,000 500,000 World 3,000,000 22,00,000 Total number of infected people: North America 940,000 1,200,000 World 40,000,000 62,000,000 Number of new infections:

707 views • 62 slides

2003 Cumulative Number of AIDS deaths: North America 20,000 500,000

HIV/AIDS in 2004*. 2003 Cumulative Number of AIDS deaths: North America 20,000 500,000 World 3,000,000 22,00,000 Total number of infected people: North America 940,000 1,200,000 World 40,000,000 62,000,000 Number of new infections:

624 views • 62 slides

CBER's policies on assay regulation: Definitions of assay performance characteristics

CBER's policies on assay regulation: Definitions of assay performance characteristics. Andrew I. Dayton, M.D., Ph.D. CBER. Regulation of In-Vitro Diagnostics (IVD). Center for Devices and Radiological Health (CDRH) Center for Biologics Evaluation and Research. IVDs in CBER.

416 views • 18 slides

Treatment as Prevention: The Key to an AIDS-Free Generation

Treatment as Prevention: The Key to an AIDS-Free Generation. Julio Montaner, MD Professor of Medicine, and Head, Div. of AIDS, University of British Columbia Director, BC-Centre for Excellence in HIV/AIDS at Providence Health Care Past President, International AIDS Society (2008-2010).

299 views • 18 slides

Management of Seroconverters

Management of Seroconverters. HIV Testing in HOPE. HIV testing will be performed at every scheduled visit and at interim visits, if indicated. HIV Testing in HOPE.

181 views • 18 slides

The Use of Dried Blood Spots in HIV Drug Resistance Surveillance

The Use of Dried Blood Spots in HIV Drug Resistance Surveillance. Diane Bennett MD MPH. U.S. HIV drug resistance (HIVDR) surveillance. Remnant HIV diagnostic sera: all individuals newly diagnosed with HIV

179 views • 17 slides

RESEARCH PROGRAM

RESEARCH PROGRAM. John W. Mellors, M.D. Professor of Medicine Chief, Division of Infectious Diseases Director, HIV/AIDS Program, UPMC mellors@dom.pitt.edu www.pitt.edu/~disease. Basic Research. Translational Research. Clinical Research. Understand Drug Resistance Discover New Drugs.

302 views • 15 slides

Field Study of the Utility of Dried Blood Spots (DBS) for HIV-1 Drug Resistance (HIVDR) Genotyping

Field Study of the Utility of Dried Blood Spots (DBS) for HIV-1 Drug Resistance (HIVDR) Genotyping. Storage for 2 Weeks and Shipping at Ambient Temperature Has No Effect on Genotyping Efficiency. Chris Parry MRC/UVRI Research Unit on AIDS. ART Roll Out.

287 views • 14 slides

Figure 2: Algorithm to reduce risks of HIV drug resistance at the ART site

Figure 2: Algorithm to reduce risks of HIV drug resistance at the ART site.

102 views • 1 slides